A9662 (2023-24 session)
NY State bill
Requires insurance companies, medical expense indemnity corporations, hospital service corporations, health service corporations and medical assistance programs to provide coverage for prescribed antiviral therapeutics approved by the food and drug administration for the treatment of COVID-19 at no cost to the patient.
- Title
- Relates to capping cost sharing for antiviral COVID-19 therapeutics
- Type
- New York State Assembly bill
- Session
- 2023-24 session
- Status
- In Assembly Committee
- Latest action date
- 2024-05-13
- In committee
- Insurance
- Introduced
- 2024-03-27
- Active version
- A9662A
- Same as
- S8367
- Law section
- Insurance Law
Sponsors
- David I. Weprin Assembly Member, District 24
Heard in committee
- Insurance NY State Assembly committee
Same as
- S8367 (2023-24 session) NY State bill